Delisting Determination,The Nasdaq Stock Market, LLC,
June 24, 2019, CytRx Corporation. The Nasdaq
Stock Market, Inc. (the Exchange) has determined to remove
from listing the common stock of CytRx Corporation
(the Company), effective at the opening of the trading
session on July 5, 2019. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5550(a)(2). The Company was notified
of the Staffs determination on May 24, 2019.  The Company
did not appeal the Staff determination to the
Hearings Panel, and the Staff determination to delist the
Company became final on June 4, 2019.